It has been co-studied with TB-500 (Thymosin Beta-4) in blended formulations for tissue recovery models
Animal studies have shown that Baicalein is an antioxidant or iron chelator, and it can significantly reduce the oxidation levels of lipids and proteins ( One study showed that baicalein could significantly improve white blood cells and hemoglobin in the bone marrow of anemic mice with regenerative disorder, and had a protective effect on apoptosis induced by iron overload
Instead of asking 'why not stack them,' the question becomes 'what specific outcome justifies adding a second compound with incomplete human safety data?' For research exploring maximal metabolic intervention where single-agent tirzepatide has plateaued, the stack may be defensible
Then weve also started to move into clinical trials
Gallbladder Disease - High amounts of niacin could worsen this condition
Neural Tube Defects Deficiency in early pregnancy increases the risk of brain and spinal cord malformations, especially when combined with low folate [*]